August 4, 2026- Henry Schein, Inc. reported financial results for the second quarter ended June 27, 2026.
Second Quarter 2026 Financial Results
- Total net sales for the quarter were $3.5 billion, an increase of 6.7% compared to the second quarter of 2025 and reflects 4.6% internal sales growth, 0.7% sales growth from acquisitions, and a 1.4% increase resulting from foreign currency exchange.
- Global Distribution and Value-Added Services sales for the quarter increased 6.6%, and reflects 4.5% internal sales growth, 0.6% sales growth from acquisitions, and a 1.5% increase resulting from foreign currency exchange compared with the second quarter of 2025. The main components are:
- Global Medical Distribution sales for the quarter increased 4.0%, and by 3.9% internal sales growth, compared with the second quarter of 2025.
- Global Value-Added Services sales for thequarter increased 5.1%, and by 3.7% internal sales growth, compared with the second quarter of 2025.
- Global Specialty Products sales for the quarter increased 8.7%, and reflects 3.2% internal sales growth, 3.4% sales growth from acquisitions, and a 2.1% increase resulting from foreign currency exchange, compared with the second quarter of 2025.
- Global Technology sales for the quarter increased 8.2%, and reflects 9.1% internal sales growth,1.3% sales decrease due to a business disposal, and a 0.4% increase resulting from foreign currency exchange, compared with the second quarter of 2025.
- GAAP net income for the quarter was $94 million, or $0.82 per diluted share, and compares with second-quarter 2025 GAAP net income of $86 million, or $0.70 per diluted share.
- Non-GAAP net income for the quarter was $145 million, or $1.27 per diluted share, and compares with second-quarter 2025 non-GAAP net income of $135 million, or $1.10 per diluted share.
- Adjusted EBITDA for the quarter was $288 million and compares with second-quarter 2025 Adjusted EBITDA of $256 million.
Continue Reading for year-to-date financial results and more from Henry Schein.